CordenPharma

We are the CDMO partner you need for safe and reliable development and manufacturing of high quality APIs, Drug Products, and Lipid Excipients to support your complex pharmaceutical modalities and ultimately, the well-being of your patients. We are a global CDMO leader in pioneering specialized lipid-based products with synthetic lipid process development, scale-up and large-scale manufacturing. Our vision is to be a trusted, reliable and highly respected CDMO by providing industry-leading Integrated Product Solutions with integrity, transparency and flexibility on all levels of the organization. On the journey to your final commercial drug product, expert support is available along the way. We draw upon decades of expertise to provide all the necessary services required to make the pathway for your drug product as smooth as possible. Our Early Phase Drug Product Innovation Centre of Excellence provides bioavailability enhancement capabilities that address the complexities associated with formulations containing solubility- or permeability-challenged APIs. We also provide enabling technologies that can solve your solubility-induced absorption issues, as well as access to a portfolio of lipid excipients for Self-Emulsifying Drug Delivery Systems (SEDDS), Self-MicroEmulsifying Drug Delivery Systems (SMEDDS), Nanocrystals, and Liposomal formulations that can resolve your permeability issues. We specialize in Lipid NanoParticle (LNP) development and manufacturing, incorporating various technologies (from microfluidics to jet impingement), as well as proper diafiltration/concentration, to produce targeted nanoparticle formulated drugs encapsulating your biological payload (e.g.